Down Syndrome: when insurers say no, reviewers often say yes
In 51 published external-review decisions involving down syndrome, independent physician reviewers overturned the insurer’s denial 74.5% of the time.
Most-fought treatments for down syndrome
| Treatment | Decisions | Overturned |
|---|---|---|
| Speech Therapy | 25 | 92% |
| Physical Therapy | 15 | 93.3% |
What the insurer actually argued
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 46 | 80.4% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 5 | 20% |
Where the denial was overturned
The parent of a two-year-old female enrollee has requested speech therapy services (provided in the home) at a frequency of two times per week, occupational therapy services (provided in the home) at a frequency of two times per week and physical therapy services (provided in the home) at a frequency of two times per week for the enrollees Down syndrome. Findings: The physician reviewer found that twice weekly speech therapy services are medically necessary to address this patient’s delays in speech and language skills and feeding skills. Many children with Down syndrome have cognitive deficits as well as difficulty with speech. Speech intelligibility, in particular, is a significant and prominent problem.
Nature of Statutory Criteria/Case Summary: The parent of an enrollee has requested authorization and coverage for speech therapy sessions (1x a week for 60 minutes)). Findings: The physician reviewer found that Areas of speech impairment in individuals with Down syndrome involve voice, speech sounds, fluency and prosody, and intelligibility. Vocal and phonatory abnormalities are common. Speech sounds are impaired due to delayed development and errors not seen in typical development. Fluency and prosody are frequently impaired due to stuttering and cluttering, which are seen in 10-45% of children with Down syndrome compared with 1% of the typical population. Intelligibility of speech can be markedly impaired in individuals with Down syndrome.
Where the denial was upheld
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement and prospective authorization and coverage for high frequency chest wall oscillation air pulse generator for treatment of the enrollee who has a history of asthma and Down’s syndrome. Findings: 2/3 of the physician reviewers found that there is minimal evidence that the use of chest wall percussive devices benefit patients with non-cystic fibrosis bronchiectasis. There are indications for a high frequency chest wall oscillation system including cystic fibrosis, bronchiectasis, or neuromuscular disorder with inability to clear secretions. While this patient has recurrent infections per the documentation provided, there is no evidence that the patient has underlying bronchiectasis, cystic fibrosis or a neuromuscular disorder that alters airway clearance.
Findings: The physician reviewer found that the patient’s parent has requested authorization and coverage for speech therapy services. The notion behind offering therapy to patients with speech-language delay is that the treatment modality will assist the patient in overcoming or coping with the pathology causing the speech-language impairment. As part of the treatment, speech-language therapists develop plans with logical and achievable goals that can be measured objectively. When these goals are met, new goals are to be established. As is the case with any therapy, the treatment modality is to be discontinued either when the patient has met the goals set, or when it has become evident that these goals are not achievable.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for down syndrome was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY